Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.5150 (-2.8%) ($8.5150 - $8.5150) on Wed. Aug. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.36% (three month average) | RSI | 53 | Latest Price | $8.5150(-2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(69%) XBI(69%) IBB(58%) ARKK(54%) IWC(52%) | Factors Impacting EDIT price | EDIT will decline at least -2.18% in a week (0% probabilities). TBT(-26%) UUP(-15%) VXX(-7%) VIXM(-5%) URA(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.18% (StdDev 4.36%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.76 | 5 Day Moving Average | $8.65(-1.56%) | 10 Day Moving Average | $8.76(-2.8%) | 20 Day Moving Average | $8.76(-2.8%) | To recent high | -25.9% | To recent low | 6.4% | Market Cap | $529m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |